349 related articles for article (PubMed ID: 7516410)
1. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.
Vallat VP; Gilleaudeau P; Battat L; Wolfe J; Nabeya R; Heftler N; Hodak E; Gottlieb AB; Krueger JG
J Exp Med; 1994 Jul; 180(1):283-96. PubMed ID: 7516410
[TBL] [Abstract][Full Text] [Related]
2. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets.
Coven TR; Murphy FP; Gilleaudeau P; Cardinale I; Krueger JG
Arch Dermatol; 1998 Oct; 134(10):1263-8. PubMed ID: 9801682
[TBL] [Abstract][Full Text] [Related]
3. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD4 monoclonal antibody therapy in severe psoriasis.
Morel P; Revillard JP; Nicolas JF; Wijdenes J; Rizova H; Thivolet J
J Autoimmun; 1992 Aug; 5(4):465-77. PubMed ID: 1384529
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
[TBL] [Abstract][Full Text] [Related]
6. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque.
Erkin G; Uğur Y; Gürer CK; Aşan E; Korkusuz P; Sahin S; Kölemen F
J Cutan Pathol; 2007 Mar; 34(3):213-9. PubMed ID: 17302604
[TBL] [Abstract][Full Text] [Related]
7. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
Oxholm A; Oxholm P; Staberg B; Bendtzen K
Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
[TBL] [Abstract][Full Text] [Related]
9. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
[TBL] [Abstract][Full Text] [Related]
11. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes.
Gottlieb S; Hayes E; Gilleaudeau P; Cardinale I; Gottlieb AB; Krueger JG
J Cutan Pathol; 1996 Oct; 23(5):404-18. PubMed ID: 8915849
[TBL] [Abstract][Full Text] [Related]
12. Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation.
Gottlieb AB; Grossman RM; Khandke L; Carter DM; Sehgal PB; Fu SM; Granelli-Piperno A; Rivas M; Barazani L; Krueger JG
J Invest Dermatol; 1992 Mar; 98(3):302-9. PubMed ID: 1372027
[TBL] [Abstract][Full Text] [Related]
13. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis.
Onuma S
J Dermatol; 1994 Apr; 21(4):223-32. PubMed ID: 7914525
[TBL] [Abstract][Full Text] [Related]
15. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.
Paukkonen K; Naukkarinen A; Horsmanheimo M
Arch Dermatol Res; 1995; 287(2):165-70. PubMed ID: 7763088
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis.
Horrocks C; Duncan JI; Sewell HF; Ormerod AD; Thomson AW
J Autoimmun; 1990 Oct; 3(5):559-70. PubMed ID: 2252524
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 protein before and after PUVA treatment in psoriasis.
Hannuksela-Svahn A; Pääkkö P; Autio P; Reunala T; Karvonen J; Vähäkangas K
Acta Derm Venereol; 1999 May; 79(3):195-9. PubMed ID: 10384915
[TBL] [Abstract][Full Text] [Related]
18. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclosporin A on resident and passenger immune cells of normal human skin and UV-induced erythema reactions.
Petzelbauer P; Wolff K
Br J Dermatol; 1992 Dec; 127(6):560-5. PubMed ID: 1362075
[TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation.
Lisby S; Ralfkiaer E; Rothlein R; Vejlsgaard GL
Br J Dermatol; 1989 Apr; 120(4):479-84. PubMed ID: 2471544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
